Age-period-cohort analysis of incidence, mortality and disability-adjusted life years of esophageal cancer in global, regional and national regions from 1990 to 2019
- PMID: 38233775
- PMCID: PMC10795420
- DOI: 10.1186/s12889-024-17706-8
Age-period-cohort analysis of incidence, mortality and disability-adjusted life years of esophageal cancer in global, regional and national regions from 1990 to 2019
Abstract
Objective: In view of the high incidence and mortality of esophageal cancer, the latest statistical data on the disease burden of esophageal cancer can provide strategies for cancer screening, early detection and treatment, and help to rationally allocate health resources. This study provides an analysis of the global disease burden and risk factors of esophageal cancer from 1990 to 2019.
Methods: Using the 2019 Global Burden of Disease, Injury and Risk Factor (GBD) data, we present the incidence, mortality and disability-adjusted life years (DALY) of esophageal cancer in 21 regions and 204 countries and different sociodemographic index (SDI) regions from 1990 to 2019. The age-period-cohort model was used to estimate the age, period, and cohort trend of esophageal cancer in different SDI regions. The estimated proportion of DALY attributable to each risk factor from 1990 to 2019.
Results: From 1990 to 2019, the number of new cases of esophageal cancer, the number of deaths and DALY increased by 67.07%, 55.97% and 42.13%, respectively, but age standardized incidence rate (ASIR), age standardized mortality rate (ASMR) and age standardized DALY rate (ASDR) decreased by 19.28%, 25.32% and 88.22%, respectively. Overall, the results of the age-period-cohort model showed that the incidence, mortality, and DALY rates in countries and regions with higher SDI levels showed a downward trend over time and with the passage of time. Conversely, there were no significant changes in incidence and mortality in countries and regions with low SDI levels. In the past 30 years, the incidence and death of esophageal cancer in the world has gradually changed to people over 80 years old, but the population aged 60-79 still accounts for the largest proportion. The global DALY in esophageal cancer is mainly attributable to smoking, followed by alcohol consumption and occupational exposure.
Conclusions: Although ASIR, ASMR and ASDR have decreased significantly, esophageal cancer is still the main factor causing the disease burden worldwide. Public health administrators in low SDI and low-middle SDI countries are high-risk areas for esophageal cancer, and preventive control measures should be implemented to raise awareness, screening, and treatment of esophageal cancer in these areas. Tobacco and alcohol control and reduction of occupational hazards are key steps in reducing the burden of esophageal cancer.
Keywords: Age-period-cohort model; Disability adjusted life year; Esophageal cancer; Incidence rate; Mortality rate.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures








Similar articles
-
Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990-2019.BMC Cancer. 2024 Aug 28;24(1):1063. doi: 10.1186/s12885-024-12835-0. BMC Cancer. 2024. PMID: 39198814 Free PMC article.
-
Burden of uterine cancer in China from 1990 to 2021 and 15-year projection: a systematic analysis and comparison with global levels.Reprod Health. 2024 Oct 10;21(1):144. doi: 10.1186/s12978-024-01882-2. Reprod Health. 2024. PMID: 39390595 Free PMC article.
-
Global burden of prostate cancer: age-period-cohort analysis from 1990 to 2021 and projections until 2040.World J Surg Oncol. 2025 Mar 20;23(1):98. doi: 10.1186/s12957-025-03733-1. World J Surg Oncol. 2025. PMID: 40114188 Free PMC article.
-
Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: Data from 1990 to 2019.Autoimmun Rev. 2024 Nov;23(11):103655. doi: 10.1016/j.autrev.2024.103655. Epub 2024 Oct 2. Autoimmun Rev. 2024. PMID: 39366514 Review.
-
Global, Regional, and National Burden of Ectopic Pregnancy: A 30-Year Observational Database Study.Int J Clin Pract. 2023 Dec 18;2023:3927337. doi: 10.1155/2023/3927337. eCollection 2023. Int J Clin Pract. 2023. PMID: 38146347 Free PMC article.
Cited by
-
Burden of esophageal cancer in global, regional and national regions from 1990 to 2021 and its projection until 2050: results from the GBD study 2021.Front Oncol. 2025 Jan 20;14:1518567. doi: 10.3389/fonc.2024.1518567. eCollection 2024. Front Oncol. 2025. PMID: 39902130 Free PMC article.
-
The Burden of Esophageal Cancer in Five East Asian Countries From 1990 to 2021 and Its Prediction Until 2036: An Analysis of the Global Burden of Diseases Study 2021.Thorac Cancer. 2025 Apr;16(8):e70045. doi: 10.1111/1759-7714.70045. Thorac Cancer. 2025. PMID: 40296590 Free PMC article.
-
A comparative analysis of the burden, trends and inequalities of tracheal, bronchus, and lung cancer in India from 2000 to 2021: A systematic analysis for the Global Burden of Disease study 2021.PLoS One. 2025 May 7;20(5):e0322646. doi: 10.1371/journal.pone.0322646. eCollection 2025. PLoS One. 2025. PMID: 40333953 Free PMC article.
-
Esophageal cancer trends in the US from 1992 to 2019 with projections to 2044 using SEER data.Sci Rep. 2025 Jul 1;15(1):22423. doi: 10.1038/s41598-025-01674-z. Sci Rep. 2025. PMID: 40592963 Free PMC article.
-
Global Immune-Nutrition-Information Index Is Independent Prognostic Factor for Gastric Cancer Patients Who Received Curative Treatment.Cancer Diagn Progn. 2024 Jul 3;4(4):489-495. doi: 10.21873/cdp.10353. eCollection 2024 Jul-Aug. Cancer Diagn Progn. 2024. PMID: 38962545 Free PMC article.
References
-
- Short MW, Burgers KG, Fry VT. Esophageal cancer. Am Fam Physician. 2017;95:22–8. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous